UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antimicrobial Susceptibility and Frequency of Occurrence of Clinical Blood Isolates in Europe from the SENTRY Antimicrobial Surveillance Program, 1997 and 1998

Clinical infectious diseases, 2000-03, Vol.30 (3), p.454-460

2000

Volltextzugriff (PDF)

In Vitro Activities of Sitafloxacin (DU-6859a) and Six Other Fluoroquinolones against 8,796 Clinical Bacterial Isolates

Antimicrobial Agents and Chemotherapy, 2000-04, Vol.44 (4), p.1102-1107

2000

Volltextzugriff (PDF)

Fluoroquinolones: structure and target sites

Current drug targets, 2003-02, Vol.4 (2), p.181-190

2003

Volltextzugriff (PDF)

Frequency of isolation and Antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 european university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998

European journal of clinical microbiology & infectious diseases, 2001-09, Vol.20 (9), p.617-625

2001

Volltextzugriff (PDF)

Activity of quinolones against gram-positive cocci: Mechanisms of drug action and bacterial resistance

European journal of clinical microbiology & infectious diseases, 2002-09, Vol.21 (9), p.647-659

2002

Volltextzugriff (PDF)

Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus

Journal of antimicrobial chemotherapy, 1998-04, Vol.41 (4), p.481-484

1998

Volltextzugriff (PDF)

Resistance integrons and super-integrons

Clinical microbiology and infection, 2004-04, Vol.10 (4), p.272-288

2004

Volltextzugriff (PDF)

Evidence for in-vivo transfer of mecA DNA between strains of Staphylococcus aureus

Lancet (British edition), 2001-05, Vol.357 (9269), p.1674-1675

2001

Volltextzugriff (PDF)

Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe : results from the SENTRY Antimicrobial Surveillance Program 1997

Antonie van Leeuwenhoek, 2000-02, Vol.77 (2), p.147-152

2000

Volltextzugriff (PDF)

In Vitro Development of Resistance to Six Quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2001-03, Vol.45 (3), p.938-942

2001

Volltextzugriff (PDF)

Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

Clinical infectious diseases, 2001-05, Vol.32 (Supplement-2), p.S114-S132

2001

Volltextzugriff (PDF)

Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins

Antimicrobial agents and chemotherapy, 1999-08, Vol.43 (8), p.2051-2055

1999

Volltextzugriff (PDF)

Molecular Detection of Antimicrobial Resistance

Clinical Microbiology Reviews, 2001-10, Vol.14 (4), p.836-e

2001

Volltextzugriff (PDF)

In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV

Antimicrobial Agents and Chemotherapy, 2002-06, Vol.46 (6), p.1651-1657

2002

Volltextzugriff (PDF)

Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study

Journal of clinical microbiology, 2001-10, Vol.39 (10), p.3727-3732

2001

Volltextzugriff (PDF)

Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe

European journal of clinical microbiology & infectious diseases, 2000-02, Vol.19 (1), p.64-68

2000

Volltextzugriff (PDF)

Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa

Journal of antimicrobial chemotherapy, 2002-08, Vol.50 (2), p.299-301

2002

Volltextzugriff (PDF)

Association of Alterations in ParC and GyrA Proteins with Resistance of Clinical Isolates of Enterococcus faecium to Nine Different Fluoroquinolones

Antimicrobial Agents and Chemotherapy, 1999-10, Vol.43 (10), p.2513-2516

1999

Volltextzugriff (PDF)

Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus

Journal of antimicrobial chemotherapy, 2002-02, Vol.49 (2), p.283-287

2002

Volltextzugriff (PDF)

In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility

Journal of antimicrobial chemotherapy, 2002-04, Vol.49 (4), p.698-701

2002

Volltextzugriff (PDF)

Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates

Antimicrobial Agents and Chemotherapy, 2003-01, Vol.47 (1), p.400-404

2003

Volltextzugriff (PDF)

Psammaplins from the Sponge Pseudoceratina purpurea: Inhibition of Both Histone Deacetylase and DNA Methyltransferase

Journal of organic chemistry, 2003-05, Vol.68 (10), p.3866-3873

2003

Volltextzugriff (PDF)

Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones

Journal of antimicrobial chemotherapy, 2002-06, Vol.49 (6), p.1015-1018

2002

Volltextzugriff (PDF)

Root Turnover: An Important Source of Microbial Substrates in Rhizosphere Remediation of Recalcitrant Contaminants

Environmental science & technology, 2002-04, Vol.36 (7), p.1579-1583

2002

Volltextzugriff (PDF)

In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones

Antimicrobial agents and chemotherapy, 2002-03, Vol.46 (3), p.934-935

2002

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(262)
Mit Volltextzugriff
(257)

Publikationsform

Sprache

Englisch
(271)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(262)
Life Sciences & Biomedicine
(197)
Biological And Medical Sciences
(150)
Pharmacology & Pharmacy
(112)
Humans
(104)
Medical Sciences
(102)
Microbiology
(96)
Pharmacology. Drug Treatments
(79)
Infectious Diseases
(73)
Chemistry
(65)
Physical Sciences
(64)
Fundamental And Applied Biological Sciences. Psychology
(59)
Animals
(57)
Plant Sciences
(54)
Microbial Sensitivity Tests
(52)
Chemistry, Medicinal
(50)
Chemistry, Organic
(49)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(48)
Antibacterial Agents
(44)
Staphylococcus Aureus - Drug Effects
(40)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antimicrobial Susceptibility and Frequency of Occurrence of Clinical Blood Isolates in Europe from the SENTRY Antimicrobial Surveillance Program, 1997 and 1998

In Vitro Activities of Sitafloxacin (DU-6859a) and Six Other Fluoroquinolones against 8,796 Clinical Bacterial Isolates

Fluoroquinolones: structure and target sites

Frequency of isolation and Antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 european university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998

Activity of quinolones against gram-positive cocci: Mechanisms of drug action and bacterial resistance

Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus

Resistance integrons and super-integrons

Evidence for in-vivo transfer of mecA DNA between strains of Staphylococcus aureus

Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe : results from the SENTRY Antimicrobial Surveillance Program 1997

In Vitro Development of Resistance to Six Quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus

Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins

Molecular Detection of Antimicrobial Resistance

In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV

Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study

Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe

Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa

Association of Alterations in ParC and GyrA Proteins with Resistance of Clinical Isolates of Enterococcus faecium to Nine Different Fluoroquinolones

Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus

In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility

Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates

Psammaplins from the Sponge Pseudoceratina purpurea: Inhibition of Both Histone Deacetylase and DNA Methyltransferase

Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones

Root Turnover: An Important Source of Microbial Substrates in Rhizosphere Remediation of Recalcitrant Contaminants

In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones

Suchergebnisse filtern